Dr Lal Pathlabs

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE600L01024
NSEID: LALPATHLAB
BSEID: 539524
View on NSE | View on BSE

INR

1,933.00

10.4 (0.54%)

BSENSE

Sep 24, 10:11 AM

BSE+NSE Vol: 1.13 lacs

{
  "main_header": {
    "sid": 1000163,
    "name": "Dr Lal Pathlabs",
    "stock_name": "Dr Lal Pathlabs",
    "full_name": "Dr Lal Pathlabs Ltd",
    "name_url": "stocks-analysis/dr-lal-pathlabs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,933.00",
    "chg": 10.4,
    "chgp": "0.54%",
    "dir": 1,
    "prev_price": "1,922.60",
    "mcapval": "32,445.18 Cr",
    "mcap": "Small Cap",
    "scripcode": 539524,
    "symbol": "LALPATHLAB",
    "ind_name": "Healthcare Services",
    "ind_code": 94,
    "sector_id": 35,
    "indexname": "India SENSEX",
    "isin": "INE600L01024",
    "curr_date": "Sep 24, 10:11 AM",
    "curr_time": "10:12 AM",
    "last_traded_at": "Sep 24, 10:11 AM IST",
    "bse_nse_vol": "1.13 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/dr-lal-pathlabs-1000163-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Dr Lal Pathlabs Ltd Dips 0.71% Despite New 52-Week High and Strong Institutional Interest",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-dips-071-despite-new-52-week-high-and-strong-institutional-interest-4198210",
        "imagepath": "",
        "date": "2026-09-19 13:02:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>15 Sep:</strong> Stock opens at Rs.1,905, declines 0.23% amid broad market weakness</p>\n                    <p><strong>16 Sep:</strong> Intraday 52-week high of Rs.2,035 reached; heavy trading volume and institutional activity</p>\n                    <p><strong>17 Sep:</strong> Price rebounds 1.73% to Rs.1,926.70, outpacing Sensex gains</p>\n                    <p><strong>18 Sep:</strong> Stock retreats 1.60% to close at Rs.1,895.85, ending the week slightly lower</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,909.40</div></div>\n                    <di..."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-buy-4197866",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/DrLalPathlabsLt_mojoScore_4197866.png",
        "date": "2026-09-19 10:10:47",
        "description": "Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing."
      },
      {
        "title": "Dr Lal Pathlabs Ltd Sees High-Value Trading Amid Institutional Interest and Positive Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-sees-high-value-trading-amid-institutional-interest-and-positive-momentum-4194675",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/DrLalPathlabsLt_most_active_equities_by_value_4194675.png",
        "date": "2026-09-16 10:00:13",
        "description": "Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has emerged as one of the most actively traded stocks by value on 16 Sep 2026, reflecting strong institutional participation and sustained investor interest. Despite a marginal dip in price, the stock’s liquidity and trading volumes underscore its appeal among market participants."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2035",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-at-rs-2035-4194811",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/DrLalPathlabsLt_priceRelatedfactors_4194811.png",
        "date": "2026-09-16 09:58:45",
        "description": "With a decisive intraday surge to Rs 2035, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This achievement comes amid a backdrop of strong technical signals that have aligned to propel the stock beyond previous resistance levels."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-buy-4186324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/DrLalPathlabsLt_mojoScore_4186324.png",
        "date": "2026-09-08 10:11:17",
        "description": "Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 September 2026, providing investors with the most up-to-date view of the company’s performance and prospects."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-buy-4173276",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DrLalPathlabsLt_mojoScore_4173276.png",
        "date": "2026-08-28 10:11:16",
        "description": "Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Dr Lal Pathlabs Ltd is Rated Buy",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/dr-lal-pathlabs-ltd-is-rated-buy-4157658",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DrLalPathlabsLt_mojoScore_4157658.png",
        "date": "2026-08-17 10:10:55",
        "description": "Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1989.35",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-at-rs-198935-4149792",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DrLalPathlabsLt_priceRelatedfactors_4149792.png",
        "date": "2026-08-12 09:55:08",
        "description": "With a decisive surge to Rs 1989.35 on 12 Aug 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to the broader market."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1971.65",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/dr-lal-pathlabs-ltd-hits-new-52-week-high-of-rs-197165-on-10-aug-2026-4145454",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/DrLalPathlabsLt_priceRelatedfactors_4145454.png",
        "date": "2026-08-10 10:14:08",
        "description": "Surpassing the Rs 1970 mark for the first time, Dr Lal Pathlabs Ltd has reached a fresh 52-week high on 10 Aug 2026, propelled by a confluence of bullish technical indicators and sustained price momentum. This milestone caps a year-long rally that has delivered a 23.16% return, comfortably outpacing the Sensex’s decline of 1.83% over the same period."
      }
    ],
    "total": 343,
    "sid": "1000163",
    "stock_news_url": "https://www.marketsmojo.com/news/dr-lal-pathlabs-1000163"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "04-Sep-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
      "datetime": "27-Aug-2026",
      "details": "Attached",
      "source": "BSE"
    },
    {
      "caption": "Incorporation Of A Step-Down Subsidiary Company",
      "datetime": "19-Aug-2026",
      "details": "Attached",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has declared <strong>50%</strong> dividend, ex-date: 30 Jul 26",
          "dt": "2026-07-30",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Dr Lal Pathlabs Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 19 Dec 25",
          "dt": "2025-12-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Dr Lal Pathlabs Ltd Dips 0.71% Despite New 52-Week High and Strong Institutional Interest

2026-09-19 13:02:58

Key Events This Week

15 Sep: Stock opens at Rs.1,905, declines 0.23% amid broad market weakness

16 Sep: Intraday 52-week high of Rs.2,035 reached; heavy trading volume and institutional activity

17 Sep: Price rebounds 1.73% to Rs.1,926.70, outpacing Sensex gains

18 Sep: Stock retreats 1.60% to close at Rs.1,895.85, ending the week slightly lower

Week Open

Rs.1,909.40

Read full news article

Dr Lal Pathlabs Ltd is Rated Buy

2026-09-19 10:10:47

Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 September 2026, providing investors with an up-to-date view of its fundamentals, returns, and market standing.

Read full news article

Dr Lal Pathlabs Ltd Sees High-Value Trading Amid Institutional Interest and Positive Momentum

2026-09-16 10:00:13

Dr Lal Pathlabs Ltd, a prominent player in the healthcare services sector, has emerged as one of the most actively traded stocks by value on 16 Sep 2026, reflecting strong institutional participation and sustained investor interest. Despite a marginal dip in price, the stock’s liquidity and trading volumes underscore its appeal among market participants.

Read full news article

Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 2035

2026-09-16 09:58:45

With a decisive intraday surge to Rs 2035, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This achievement comes amid a backdrop of strong technical signals that have aligned to propel the stock beyond previous resistance levels.

Read full news article

Dr Lal Pathlabs Ltd is Rated Buy

2026-09-08 10:11:17

Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 08 September 2026, providing investors with the most up-to-date view of the company’s performance and prospects.

Read full news article

Dr Lal Pathlabs Ltd is Rated Buy

2026-08-28 10:11:16

Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 August 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Dr Lal Pathlabs Ltd is Rated Buy

2026-08-17 10:10:55

Dr Lal Pathlabs Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 24 July 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 17 August 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1989.35

2026-08-12 09:55:08

With a decisive surge to Rs 1989.35 on 12 Aug 2026, Dr Lal Pathlabs Ltd has reached a fresh 52-week high, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals and sustained outperformance relative to the broader market.

Read full news article

Broad-Based Technical Strength Lifts Dr Lal Pathlabs Ltd to 52-Week High of Rs 1971.65

2026-08-10 10:14:08

Surpassing the Rs 1970 mark for the first time, Dr Lal Pathlabs Ltd has reached a fresh 52-week high on 10 Aug 2026, propelled by a confluence of bullish technical indicators and sustained price momentum. This milestone caps a year-long rally that has delivered a 23.16% return, comfortably outpacing the Sensex’s decline of 1.83% over the same period.